Early research (Phase 1)UnknownNCT04000906What this trial is testingPIPAC With Nab-paclitaxel and Cisplatin in Peritoneal CarcinomatosisWho this might be right forPeritoneal Carcinomatosis University Hospital, Geneva 18
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00066651What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced Solid TumorsWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT06756035What this trial is testingCT-95 in Advanced Cancers Associated With Mesothelin ExpressionWho this might be right forMesothelin-Expressing TumorsEpithelial Ovarian CancerMalignant Pleural Mesothelioma, Advanced+8 more Context Therapeutics Inc. 70
Testing effectiveness (Phase 2)Temporarily pausedNCT05337735What this trial is testingA Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare CancersWho this might be right forMicrosatellite High CancersPeritoneal MesotheliomaExtrapulmonary High Grade+5 more M.D. Anderson Cancer Center 140
Early research (Phase 1)Ended earlyNCT06299163What this trial is testingNM32-2668 in Adult Patients With Selected Advanced Solid TumorsWho this might be right forOvarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma+10 more Numab Therapeutics AG 11
Testing effectiveness (Phase 2)Looking for participantsNCT06543069What this trial is testingSintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeMWho this might be right forMalignant Peritoneal Mesothelioma, Advanced Cancer Institute and Hospital, Chinese Academy of Medical Sciences 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05451849What this trial is testingA Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing CancerWho this might be right forMesotheliomaMesotheliomas PleuralMesothelioma, Malignant+14 more TCR2 Therapeutics 6
Not applicableEnded earlyNCT00028782What this trial is testingEF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural CancerWho this might be right forAdvanced Malignant MesotheliomaLocalized Malignant MesotheliomaMalignant Ascites+2 more National Cancer Institute (NCI) 80
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Study completedNCT00006981What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced CancerWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT03507452What this trial is testingFirst-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express MesothelinWho this might be right forAdvanced Recurrent Malignant Pleural Epithelioid MesotheliomaAdvanced Recurrent Malignant Peritoneal Epithelioid MesotheliomaAdvanced Recurrent Serous Ovarian Cancer+1 more Bayer 36
Testing effectiveness (Phase 2)UnknownNCT00024271What this trial is testingSurgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal CancerWho this might be right forMalignant Mesothelioma Herbert Irving Comprehensive Cancer Center
Large-scale testing (Phase 3)UnknownNCT00003034What this trial is testingONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy RegimenWho this might be right forMalignant Mesothelioma Alfacell 300
Early research (Phase 1)Study completedNCT00055705What this trial is testingPV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05579366What this trial is testingRinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)Who this might be right forHigh Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12 more Genmab 884
Early research (Phase 1)Study completedNCT00398138What this trial is testingVaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or MesotheliomaWho this might be right forLeukemiaLung CancerMalignant Mesothelioma+2 more Memorial Sloan Kettering Cancer Center 22
Testing effectiveness (Phase 2)Ended earlyNCT05500508What this trial is testingOral AMXT 1501 Dicaprate in Combination With IV DFMOWho this might be right forCancerSolid TumorSolid Carcinoma+17 more Aminex Therapeutics, Inc. 15
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Ended earlyNCT03608618What this trial is testingIntraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal MesotheliomaWho this might be right forPeritoneal MesotheliomaFallopian Tube AdenocarcinomaAdenocarcinoma of the Ovary+1 more MaxCyte, Inc. 14